Human Tissue Microarray (OV068-01A)
Epithelial ovarian cancer tissue microarray contains 3 cases of Mucinous carcinoma, 13 cases of Endometrioid Adenocarcinoma, and 18 cases of high-grade serous carcinoma. 2 cores per case. Pathology grade, TNM and Stage information are available.
$220.00
| Species | Human |
|---|---|
| Section Thickness | 5 µm |
| Fixative | Formalin |
| Total Cases | 34 |
| Total Cores | 68 |
| Core Diameter | 1.5 mm |
| Storage | Short term RT |
| Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- OV
- OV
- OV
- OV
- OV
- OV
- B
- OV
- OV
- OV
- OV
- OV
- OV
- C
- OV
- OV
- OV
- OV
- OV
- OV
- D
- OV
- OV
- OV
- OV
- OV
- OV
- E
- OV
- OV
- OV
- OV
- OV
- OV
- F
- OV
- OV
- OV
- OV
- OV
- OV
- G
- OV
- OV
- OV
- OV
- OV
- OV
- H
- OV
- OV
- OV
- OV
- OV
- OV
- I
- OV
- OV
- OV
- OV
- OV
- OV
- J
- OV
- OV
- OV
- OV
- OV
- OV
- K
- OV
- OV
- OV
- OV
- OV
- OV
- L
- OV
- OV
- OV
- OV
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
| No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
A1
|
44
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-02
|
|
2
|
A2
|
44
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-02
|
|
3
|
A3
|
36
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-10
|
|
4
|
A4
|
36
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-10
|
|
5
|
A5
|
69
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-368
|
|
6
|
A6
|
69
|
F
|
Ovary
|
Mucinous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-368
|
|
7
|
B1
|
28
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M0
|
III
|
Malignant Primary
|
OV-32
|
|
8
|
B2
|
28
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M0
|
III
|
Malignant Primary
|
OV-32
|
|
9
|
B3
|
69
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G4
|
T2N1M1
|
IV
|
Malignant Primary
|
OVA-702
|
|
10
|
B4
|
69
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G4
|
T2N1M1
|
IV
|
Malignant Primary
|
OVA-702
|
|
11
|
B5
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-50
|
|
12
|
B6
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-50
|
|
13
|
C1
|
76
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N0M0
|
III
|
Malignant Primary
|
OV-55
|
|
14
|
C2
|
76
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N0M0
|
III
|
Malignant Primary
|
OV-55
|
|
15
|
C3
|
46
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-69
|
|
16
|
C4
|
46
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-69
|
|
17
|
C5
|
44
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-70
|
|
18
|
C6
|
44
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-70
|
|
19
|
D1
|
37
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-71
|
|
20
|
D2
|
37
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-71
|
|
21
|
D3
|
68
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-82
|
|
22
|
D4
|
68
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-82
|
|
23
|
D5
|
34
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-91
|
|
24
|
D6
|
34
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-91
|
|
25
|
E1
|
55
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-29
|
|
26
|
E2
|
55
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-29
|
|
27
|
E3
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-43
|
|
28
|
E4
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-43
|
|
29
|
E5
|
72
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-75
|
|
30
|
E6
|
72
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-75
|
|
31
|
F1
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-98
|
|
32
|
F2
|
65
|
F
|
Ovary
|
Endometrioid Adenocarcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-98
|
|
33
|
F3
|
38
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-136
|
|
34
|
F4
|
38
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-136
|
|
35
|
F5
|
70
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-138
|
|
36
|
F6
|
70
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-138
|
|
37
|
G1
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M0
|
III
|
Malignant Primary
|
OV-168
|
|
38
|
G2
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M0
|
III
|
Malignant Primary
|
OV-168
|
|
39
|
G3
|
74
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-225
|
|
40
|
G4
|
74
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-225
|
|
41
|
G5
|
69
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-239
|
|
42
|
G6
|
69
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-239
|
|
43
|
H1
|
34
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-257
|
|
44
|
H2
|
34
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-257
|
|
45
|
H3
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-275
|
|
46
|
H4
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-275
|
|
47
|
H5
|
41
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-30
|
|
48
|
H6
|
41
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-30
|
|
49
|
I1
|
34
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-301
|
|
50
|
I2
|
34
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-301
|
|
51
|
I3
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-323
|
|
52
|
I4
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-323
|
|
53
|
I5
|
45
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-372
|
|
54
|
I6
|
45
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-372
|
|
55
|
J1
|
67
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-394
|
|
56
|
J2
|
67
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
OV-394
|
|
57
|
J3
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T1N1M1
|
IV
|
Malignant Primary
|
OV-414
|
|
58
|
J4
|
56
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T1N1M1
|
IV
|
Malignant Primary
|
OV-414
|
|
59
|
J5
|
54
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T1N0M1
|
IV
|
Malignant Primary
|
OV-474
|
|
60
|
J6
|
54
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T1N0M1
|
IV
|
Malignant Primary
|
OV-474
|
|
61
|
K1
|
61
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-511
|
|
62
|
K2
|
61
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-511
|
|
63
|
K3
|
33
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-597
|
|
64
|
K4
|
33
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OV-597
|
|
65
|
K5
|
39
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-88
|
|
66
|
K6
|
39
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N1M1
|
IV
|
Malignant Primary
|
OV-88
|
|
67
|
L1
|
53
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OVA-680
|
|
68
|
L2
|
53
|
F
|
Ovary
|
High Grade Serous Carcinoma
|
G3
|
T2N0M1
|
IV
|
Malignant Primary
|
OVA-680
|
|
69
|
L3
|
Tissue Marker
|
N-105
|
|||||||
|
70
|
L4
|
Tissue Marker
|
N-105
|
